Management of multi-drug resistant organisms in healthcare settings
نویسندگان
چکیده
منابع مشابه
Perioperative management of multidrug-resistant organisms in health care settings.
Guidelines for managing multidrug-resistant organisms (MDROs) in health care settings were published by the Healthcare Infection Control Practices Advisory Committee (HICPAC) in October 2006. These guidelines outline appropriate strategies to help prevent MDRO cross transmission. Perioperative nurses should be prepared to implement these strategies in an effort to protect their surgical patient...
متن کاملManagement of multidrug-resistant organisms in health care settings, 2006.
Acknowledgement: The authors and HICPAC gratefully acknowlege Dr. Larry Strausbaugh for his many contributions and valued guidance in the preparation of this guideline.
متن کاملEmergence of Multi-Drug-Resistant Organisms (MDROs) Causing Fournier’s Gangrene
BACKGROUND Fournier's gangrene is an uncommon but often devastating infection. There are few contemporary data on the risk factors and evolving microbiologic trends including drug-resistant organisms implicated in these life-threatening infections. METHODS A retrospective study of Fournier's gangrene from 2006 to 2015 at a large academic hospital was conducted. Cases were identified using ICD...
متن کاملRecommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper .
How to cite this article: Adam L. Cohen, David Calfee, Scott K. Fridkin, Susan S. Huang, John A. Jernigan, Ebbing Lautenbach, Shannon Oriola, Keith M. Ramsey, Cassandra D. Salgado and Robert A. Weinstein (2008). Recommendations For Metrics For Multidrug-Resistant Organisms In Healthcare Settings: SHEA/HICPAC Position Paper. Infection Control & Hospital Epidemiology, 29, pp 901-913 doi:10.1086/5...
متن کاملCarbapenem-resistant Acinetobacter baumannii in healthcare settings
Carbapenem-resistant A. baumannii poses a significant threat to patients and healthcare systems in all EU/EEA countries. A. baumannii is the cause of serious infections in healthcare settings, and carbapenem resistance limits treatment options and increases the risk for adverse outcomes for patients. The epidemiological situation in Europe has worsened in the past years, with a higher number of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Korean Medical Association
سال: 2018
ISSN: 1975-8456,2093-5951
DOI: 10.5124/jkma.2018.61.1.26